Table 5 The effect of interventions on aldosterone and plasma renin activity (PRA)
Length of follow-up | p* | p† | ||
---|---|---|---|---|
Baseline | 120 min | |||
Aldosterone, ng/dL | ||||
Group 1 | 56.1 (51.3–60.9) | 64.7 (59.9–69.6) | <0.001 | <0.001 |
Group 2 | 59.2 (54.3–64.0) | 56.6 (51.8–61.5) | ||
Group 3 | 52.0 (47.2–56.9) | 56.4 (51.6–61.3) | ||
Group 4 | 58.8 (53.9–63.6) | 57.4 (52.6–62.3) | ||
p‡ | 0.15 | <0.001 | ||
PRA, ng/mLh | ||||
Group 1 | 1.7 (1.4–2.0) | 2.3 (2.0–2.6) | <0.001 | <0.001 |
Group 2 | 1.4 (1.1–1.7) | 1.4 (1.1–1.7) | ||
Group 3 | 1.4 (1.0–1.7) | 1.7 (1.3–1.9) | ||
Group 4 | 1.2 (0.9–1.6) | 1.3 (0.9–1.6) | ||
p‡ | 0.25 | <0.001 |